SIMPLIFIED LIQUID-CHROMATOGRAPHY ASSAY FOR THE QUANTITATION OF HALOFANTRINE AND DESBUTYLHALOFANTRINE IN PLASMA AND IDENTIFICATION OF A DEGRADATION PRODUCT OF DESBUTYLHALOFANTRINE FORMED UNDER ALKALINE CONDITIONS

被引:47
作者
HUMBERSTONE, AJ
CURRIE, GJ
PORTER, CJH
SCANLON, MJ
CHARMAN, WN
机构
[1] MONASH UNIV,VICTORIAN COLL PHARM,DEPT PHARMACEUT,PARKVILLE,VIC 3052,AUSTRALIA
[2] UNIV MELBOURNE,PLANT CELL BIOL RES CTR,PARKVILLE,VIC 3052,AUSTRALIA
关键词
HALOFANTRINE; PLASMA ASSAY; STABILITY; LC;
D O I
10.1016/0731-7085(95)01256-K
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The development of a new and simplified, validated LC assay for the quantitation of halofantrine and desbutylhalofantrine in plasma is described. The methodology employs an inexpensive, rapid and simple liquid-liquid extraction procedure in combination with previously reported chromatographic conditions. The method has been employed to study aspects of the pharmacokinetics of orally administered halofantrine in beagle dogs and some preliminary data are presented. During development of the extraction procedure, degradation of desbutylhalofantrine was observed under non-acidic conditions in the extraction solvent (tert-butyl methyl ether) and we also report the structural elucidation of the breakdown product and the conditions required to avoid this degradation.
引用
收藏
页码:265 / 272
页数:8
相关论文
共 10 条
  • [1] BERGMANN ED, 1959, RECL TRAV CHIM PAY B, V78, P315
  • [2] HALOFANTRINE - A REVIEW OF ITS ANTIMALARIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL
    BRYSON, HM
    GOA, KL
    [J]. DRUGS, 1992, 43 (02) : 236 - 258
  • [3] ION-PAIRED LIQUID-CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF BLOOD AND PLASMA FOR THE ANTIMALARIAL DRUG HALOFANTRINE AND ITS PUTATIVE MONO-DEBUTYLATED METABOLITE
    GAWIENOWSKI, M
    BENET, LZ
    FLECKENSTEIN, L
    LIN, ET
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 430 (02): : 412 - 419
  • [4] AN IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS MEASUREMENT OF HALOFANTRINE AND DESBUTYLHALOFANTRINE IN HUMAN SERUM
    KEERATITHAKUL, D
    TEJAISAVADHARM, P
    SHANKS, GD
    WEBSTER, HK
    EDSTEIN, MD
    [J]. THERAPEUTIC DRUG MONITORING, 1991, 13 (01) : 64 - 68
  • [5] MEASUREMENT OF HALOFANTRINE AND ITS MAJOR METABOLITE DESBUTYLHALOFANTRINE IN PLASMA AND BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - A NEW METHODOLOGY
    MBERU, EK
    MUHIA, DK
    WATKINS, WM
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 581 (01): : 156 - 160
  • [6] MILTON KA, 1988, J CHROMATOGR-BIOMED, V433, P339
  • [7] PHARMACOKINETICS OF HALOFANTRINE IN MAN - EFFECTS OF FOOD AND DOSE SIZE
    MILTON, KA
    EDWARDS, G
    WARD, SA
    ORME, ML
    BRECKENRIDGE, AM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) : 71 - 77
  • [8] PHOTOLYTIC DEGRADATION OF ALPHA-[(DIBUTYLAMINO)METHYL]-6,8-DICHLORO-2-(3',4'-DICHLOROPHENYL)-4-QUINOLINE METHANOL - EXPERIMENTAL ANTIMALARIAL
    OKADA, H
    STELLA, V
    HASLAM, J
    YATA, N
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) : 1665 - 1667
  • [9] HALOFANTRINE VERSUS MEFLOQUINE IN TREATMENT OF MULTIDRUG-RESISTANT FALCIPARUM-MALARIA
    TERKUILE, FO
    DOLAN, G
    NOSTEN, F
    EDSTEIN, MD
    LUXEMBURGER, C
    PHAIPUN, L
    CHONGSUPHAJAISIDDHI, T
    WEBSTER, HK
    WHITE, NJ
    [J]. LANCET, 1993, 341 (8852) : 1044 - 1049
  • [10] WHITE NJ, 1992, BRIT J CLIN PHARMACO, V34, P1